Morningstar Investment Management LLC Buys 35,506 Shares of The Clorox Company $CLX

Morningstar Investment Management LLC grew its stake in shares of The Clorox Company (NYSE:CLX) by 131.8% in the 4th quarter, HoldingsChannel.com reports. The fund owned 62,454 shares of the company’s stock after acquiring an additional 35,506 shares during the period. Morningstar Investment Management LLC’s holdings in Clorox were worth $6,297,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of CLX. Center for Financial Planning Inc. bought a new stake in shares of Clorox during the third quarter valued at approximately $25,000. Vermillion & White Wealth Management Group LLC bought a new stake in shares of Clorox during the third quarter valued at approximately $25,000. Root Financial Partners LLC bought a new stake in shares of Clorox during the third quarter valued at approximately $29,000. Darwin Wealth Management LLC bought a new stake in shares of Clorox during the second quarter valued at approximately $29,000. Finally, Vision Financial Markets LLC raised its stake in shares of Clorox by 166.7% during the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after acquiring an additional 200 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of NYSE:CLX opened at $94.97 on Monday. The company has a market capitalization of $11.48 billion, a price-to-earnings ratio of 15.42, a price-to-earnings-growth ratio of 0.49 and a beta of 0.59. The Clorox Company has a 52 week low of $84.70 and a 52 week high of $132.03. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The firm has a 50 day moving average of $99.99 and a 200 day moving average of $106.27.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the previous year, the firm posted $1.45 earnings per share. Clorox’s revenue for the quarter was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, sell-side analysts predict that The Clorox Company will post 5.61 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, May 8th. Shareholders of record on Wednesday, April 22nd were issued a $1.24 dividend. This represents a $4.96 annualized dividend and a yield of 5.2%. The ex-dividend date of this dividend was Wednesday, April 22nd. Clorox’s payout ratio is currently 80.52%.

Insider Transactions at Clorox

In other news, Director Pierre R. Breber purchased 5,000 shares of the business’s stock in a transaction on Tuesday, May 5th. The shares were acquired at an average cost of $85.82 per share, with a total value of $429,100.00. Following the completion of the acquisition, the director owned 18,000 shares of the company’s stock, valued at $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.63% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the stock. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $91.00 price target on shares of Clorox in a research note on Friday, May 1st. Royal Bank Of Canada reduced their price objective on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a research note on Thursday, April 9th. TD Cowen boosted their price objective on shares of Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research note on Tuesday, March 31st. Wells Fargo & Company reduced their price objective on shares of Clorox from $100.00 to $95.00 and set an “equal weight” rating for the company in a research note on Monday, May 18th. Finally, Evercore reissued an “underperform” rating and issued a $110.00 price objective on shares of Clorox in a research note on Friday, May 1st. One equities research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Reduce” and an average price target of $103.40.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.